Hugh Alsop
Chief Executive Officer, Co-Founder

Hugh is an accomplished biotech executive with over 22 years of experience in drug development for global markets, pharmaceutical commercialization, international business development and partnering, general management and profit accountability.

Hugh has worked in executive positions for a wide spectrum of pharmaceutical and biotechnology companies, including Hatchtech, Acrux, SigmaPharmaceuticals, Mayne Pharma, and Faulding Pharmaceuticals, and also serves as a non-executive Director on the Board of Australian biopharmaceutical companies, Dimerix Pty Ltd and Servatus Pty Ltd.